AGREEMENT AND PLAN OF MERGER among INFINITY PHARMACEUTICALS, INC. MEI PHARMA, INC. and MEADOW MERGER SUB, INC. Dated as of February 22, 2023Agreement and Plan of Merger • February 23rd, 2023 • MEI Pharma, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledFebruary 23rd, 2023 Company Industry JurisdictionTHIS AGREEMENT AND PLAN OF MERGER (hereinafter referred to as this “Agreement”), dated as of February 22, 2023, among Infinity Pharmaceuticals, Inc., a Delaware corporation (“Iris”), MEI Pharma, Inc., a Delaware corporation (“Meadow”), and Meadow Merger Sub, Inc., a Delaware corporation and a wholly owned Subsidiary of Meadow (“Merger Sub”). Meadow, Merger Sub and Iris are each sometimes referred to herein as a “Party” and collectively as the “Parties”.
AGREEMENT AND PLAN OF MERGER among INFINITY PHARMACEUTICALS, INC., MEI PHARMA, INC. and MEADOW MERGER SUB, INC. Dated as of February 22, 2023Agreement and Plan of Merger • February 23rd, 2023 • Infinity Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledFebruary 23rd, 2023 Company Industry JurisdictionTHIS AGREEMENT AND PLAN OF MERGER (hereinafter referred to as this “Agreement”), dated as of February 22, 2023, among Infinity Pharmaceuticals, Inc., a Delaware corporation (“Iris”), MEI Pharma, Inc., a Delaware corporation (“Meadow”), and Meadow Merger Sub, Inc., a Delaware corporation and a wholly owned Subsidiary of Meadow (“Merger Sub”). Meadow, Merger Sub and Iris are each sometimes referred to herein as a “Party” and collectively as the “Parties”.
AGREEMENT AND PLAN OF MERGER among INFINITY PHARMACEUTICALS, INC., MEI PHARMA, INC. and MEADOW MERGER SUB, INC. Dated as of February 22, 2023Agreement and Plan of Merger • February 23rd, 2023 • Infinity Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledFebruary 23rd, 2023 Company Industry JurisdictionTHIS AGREEMENT AND PLAN OF MERGER (hereinafter referred to as this “Agreement”), dated as of February 22, 2023, among Infinity Pharmaceuticals, Inc., a Delaware corporation (“Iris”), MEI Pharma, Inc., a Delaware corporation (“Meadow”), and Meadow Merger Sub, Inc., a Delaware corporation and a wholly owned Subsidiary of Meadow (“Merger Sub”). Meadow, Merger Sub and Iris are each sometimes referred to herein as a “Party” and collectively as the “Parties”.